Category: AppleSyndicate content

Hacker demonstrates insulin pump attack from 300 ft. away | On Call

March 1, 2012 by MassDevice staff

A hacker and McAfee researcher demonstrates how an insulin pump can be controlled wirelessly and forced to inject a lethal dose from a distance.

MassDevice On Call

MASSDEVICE ON CALL — A modern insulin pump can be hacked from 300 feet away and told to deliver a lethal dose of insulin, a hacker and researcher for computer security giant McAfee proved.

Using a laptop and a custom-made antennae, Barnaby Jack's software broke through the insulin pump's security and altered its program to dump its contents, injected a potentially lethal dose of the hormone into a dummy pancreas used for demonstration purposes.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Diabetes: Medtronic launches new remote glucose monitor | On Call

January 4, 2012 by MassDevice staff

Medtronic lands FDA approval for its mySentry remote glucose monitor.

MassDevice On Call

MASSDEVICE ON CALL — Medtronic (NYSE:MDT) landed FDA approval for its mySentry remote glucose monitor, which delivers real-time insulin pump stats and glucose trends.

The Minneapolis, Minn.-based medical device titan's system links with the MiniMed Paradigm insulin pump to allow caregivers to set alarms and remotely monitor patients' glucose levels.

MassDevice Reader's choice | The 5 best reads of 2011

December 27, 2011 by Emily Greenhalgh

Bin Laden's kidney disease, St. Jude's CEO slams Medtronic, med-tech to save Steve Jobs, DNA tests show incest and Bill Hawkins on leaving MDT were the most popular medical device stories of 2011.

Plus 3

Welcome to MassDevice's annual audit of the ups, downs and in-betweens of the year that was. For the medical device industry, 2011 was more or less defined by a nagging sense of uncertainty that hung over the world's med-tech companies like a grey cloud above a summer picnic.

But what did we learn from all the conjecture? In truth, not much. The year ends much as it began, full of questions with no cut and dry answers as we turn the calenFdar over into the new year.

Breast cancer: Faulty breast implants in France | On Call

December 21, 2011 by MassDevice staff

French authorities may ask 30,000 women to have a potentially defective type of breast implant removed.

MassDevice On Call

MASSDEVICE ON CALL — French authorities need to decide whether or not they're going to ask 30,000 women to have their breast implants removed.

The potentially defective implants were supplied by Poly Implant Prothese and contain a non-authorized silicone gel that causes high rupture rates.

"We have to remove all these implants," Dr. Laurent Lantieri, a plastic surgeon on a special committee investigating the issue told the Liberation newspaper. "We're facing a health crisis, linked to a fraud."

Diabetes: WPI team gets $1.2M for diabetes care app | Funding Roundup

December 13, 2011 by MassDevice staff

A research team from Worcester Polytechnic Institute lands $1.2 million from the National Science Foundation to develop a diabetes care smart phone app.

A research team from Worcester Polytechnic Institute won a $1.2 million grant from the National Science Foundation to develop a smart phone app for people with advanced diabetes.

The proposed application, currently named "sugar," will link a patient's smart phone, glucose meter and scale to track and archive blood sugar levels and weight. Patients with foot ulcers will be able to use the phone's camera to capture and analyze images of the lesions. +3 | CardioMEMS CEO on FDA ruling, iPhone glucose meter, Stryker cuts 160 jobs

December 9, 2011 by MassDevice staff

The top three medical device stories for December 9, 2011.

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of's coverage highlights our three biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you're still in the know with MassDevice +3.

Diabetes: FDA clears iPhone glucose meter | On Call

December 8, 2011 by MassDevice staff

Sanofi's iBGStar becomes first iPhone glucose meter to land FDA clearance.

MassDevice On Call

MASSDEVICE ON CALL — Sanofi’s (NYSE:SNY) iPhone glucose meter, the iBGStar, landed 510(k) clearance from the FDA, making it the first iPhone glucose meter to win a nod from the federal watchdog agency.

The company's website describes the meter as "is the first available blood glucose meter that seamlessly connects to the Apple iPhone and iPod touch for the flexibility to manage your diabetes whenever, wherever."